Revvity rises after upbeat commentary at healthcare investor conferences
+9.11% to $140.19 from $128.49
What moved RVTY
- Revvity shares rose following management’s presentation at Baird’s 2026 Global Healthcare Conference, one of a string of fireside chats this week where executives discussed the company’s strategic priorities.
- A day earlier at the Morgan Stanley 24th Annual Global Healthcare Conference, Revvity’s CFO said the company has sharpened its focus on differentiated life-sciences and diagnostics offerings while navigating uneven demand in some end markets and a lengthy China-business divestiture process.
Sources: Revvity Investor Relations · Seeking Alpha